Digitisation | April 06, 2022
Hataali wins US patent for the use of blockchain in advanced medicinal therapy
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved
Under the terms of the agreement, Vipergen will apply its in-living-cell DNA-encoded library (DEL) screening platform to discover novel small-molecule compounds that bind to a selected Theseus kinase target
The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021
Companies to leverage proprietary IgM antibody technology platform to discover agonists against three oncology targets and three immunology/inflammation targets
_256_384.jpg)
The Indian companies that have been granted licences are Cipla, Sun Pharma, Laurus Labs, Divis Labs, Glenmark, Cadila, Torrent, Emcure, McLeods, SMS Pharmaceuticals, Strides, Biocon, Aurobindo Pharma, Hetero, Granules, Amneal, MSN, Arene Life Sciences and Viatris
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
Jointly fund and develop up to three antibody-drug conjugate programs for the treatment of cancer
Selvax's goal is to develop safe, effective and immunological-based treatments for a range of hard-to-treat solid tumours
This collaboration has resulted in several high-impact scientific publications describing breakthrough inventions, including the SOMA robotic pill, which has subsequently been licensed exclusively to Novo Nordisk for clinical development
Subscribe To Our Newsletter & Stay Updated
